{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:44Z","timestamp":1789517624478,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12872-018-0762-z","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T08:32:00Z","timestamp":1517905920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-3751","authenticated-orcid":false,"given":"Hong","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqiong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","volume":"19","author":"GR Lewin","year":"1996","unstructured":"Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci. 1996;19:289\u2013317.","journal-title":"Annu Rev Neurosci"},{"key":"762_CR2","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1242\/dev.127.21.4531","volume":"127","author":"MJ Donovan","year":"2000","unstructured":"Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development. 2000;127:4531\u201340.","journal-title":"Development"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tcm.2007.03.002","volume":"17","author":"P Kermani","year":"2007","unstructured":"Kermani P, Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med. 2007;17:140\u20133.","journal-title":"Trends Cardiovasc Med"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/apha.12249","volume":"211","author":"T Usui","year":"2014","unstructured":"Usui T, Naruo A, Okada M, Hayabe Y, Yamawaki H. Brain-derived neurotrophic factor promotes angiogenic tube formation through generation of oxidative stress in human vascular endothelial cells. Acta Physiol (Oxf). 2014;211:385\u201394.","journal-title":"Acta Physiol (Oxf)"},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1006\/prep.1995.1062","volume":"6","author":"RD Rosenfeld","year":"1995","unstructured":"Rosenfeld RD, Zeni L, Haniu M, Talvenheimo J, Radka SF, Bennett L, et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif. 1995;6:465\u201371.","journal-title":"Protein Expr Purif"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0079-6123(03)46018-4","volume":"146","author":"GN Chaldakov","year":"2004","unstructured":"Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res. 2004;146:279\u201389.","journal-title":"Prog Brain Res"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-006-0537-4","volume":"50","author":"KS Krabbe","year":"2007","unstructured":"Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2007;50:431\u20138.","journal-title":"Diabetologia"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2004.10.041","volume":"102","author":"L Manni","year":"2005","unstructured":"Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol. 2005;102:169\u201371.","journal-title":"Int J Cardiol"},{"key":"762_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2011.10.020","volume":"415","author":"H Jiang","year":"2011","unstructured":"Jiang H, Liu Y, Zhang Y, Chen ZY. Association of plasma brain-derived neurotrophic factor and cardiovascular risk factors and prognosis in angina pectoris. Biochem Biophys Res Commun. 2011;415:99\u2013103.","journal-title":"Biochem Biophys Res Commun"},{"key":"762_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001544","volume":"4","author":"BM Kaess","year":"2015","unstructured":"Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, et al. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc. 2015;4:e001544.","journal-title":"J Am Heart Assoc"},{"key":"762_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140668","volume":"10","author":"M Rodier","year":"2015","unstructured":"Rodier M, Quirie A, Prigent-Tessier A, Bejot Y, Jacquin A, Mossiat C, et al. Relevance of post-stroke circulating BDNF levels as a prognostic biomarker of stroke outcome. Impact of rt-PA treatment. PLoS One. 2015;10:e0140668.","journal-title":"PLoS One"},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5487\/TR.2014.30.2.091","volume":"30","author":"KW Kim","year":"2014","unstructured":"Kim KW, Won YL, Ko KS, Roh JW. Smoking habits and neuropeptides: adiponectin, brain-derived neurotrophic factor, and leptin levels. Toxicol Res. 2014;30:91\u20137.","journal-title":"Toxicol Res"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3389\/fnhum.2014.00985","volume":"8","author":"RL Leckie","year":"2014","unstructured":"Leckie RL, Oberlin LE, Voss MW, Prakash RS, Szabo-Reed A, Chaddock-Heyman L, et al. BDNF mediates improvements in executive function following a 1-year exercise intervention. Front Hum Neurosci. 2014;8:985.","journal-title":"Front Hum Neurosci"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/cvr\/cvt219","volume":"100","author":"A Prigent-Tessier","year":"2013","unstructured":"Prigent-Tessier A, Quirie A, Maguin-Gate K, Szostak J, Mossiat C, Nappey M, et al. Physical training and hypertension have opposite effects on endothelial brain-derived neurotrophic factor expression. Cardiovasc Res. 2013;100:374\u201382.","journal-title":"Cardiovasc Res"},{"key":"762_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/HJH.0000000000001164","volume":"35","author":"A Monnier","year":"2017","unstructured":"Monnier A, Garnier P, Quirie A, Pernet N, Demougeot C, Marie C, et al. Effect of short-term exercise training on brain-derived neurotrophic factor signaling in spontaneously hypertensive rats. J Hypertens. 2017;35:279\u201390.","journal-title":"J Hypertens"},{"key":"762_CR16","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cca.2012.02.013","volume":"413","author":"IT Lee","year":"2012","unstructured":"Lee IT, Lee WJ, Tsai IC, Liang KW, Lin SY, Wan CJ, et al. Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. Clin Chim Acta. 2012;413:944\u20138.","journal-title":"Clin Chim Acta"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhh.2014.39","volume":"29","author":"AJ Smith","year":"2015","unstructured":"Smith AJ, Malan L, Uys AS, Malan NT, Harvey BH, Ziemssen T. Attenuated brain-derived neurotrophic factor and hypertrophic remodelling: the SABPA study. J Hum Hypertens. 2015;29:33\u20139.","journal-title":"J Hum Hypertens"},{"key":"762_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"762_CR19","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","volume":"120","author":"ZM Ruggeri","year":"2007","unstructured":"Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res. 2007;120(Suppl 1):S5\u20139.","journal-title":"Thromb Res"},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","volume":"4","author":"UM Vischer","year":"2006","unstructured":"Vischer UM. Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4:1186\u201393.","journal-title":"J Thromb Haemost"},{"key":"762_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1160\/TH14-07-0589","volume":"113","author":"MA Sonneveld","year":"2015","unstructured":"Sonneveld MA, Cheng JM, Oemrawsingh RM, de Maat MP, Kardys I, Garcia-Garcia HM, et al. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study. Thromb Haemost. 2015;113:577\u201384.","journal-title":"Thromb Haemost"},{"key":"762_CR22","first-page":"826","volume":"44","author":"DY Hu","year":"2016","unstructured":"Hu DY. New guidelines and evidence for the prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:826\u20137.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999\u20133054.","journal-title":"Eur Heart J"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"762_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00125-009-1364-1","volume":"52","author":"VB Matthews","year":"2009","unstructured":"Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia. 2009;52:1409\u201318.","journal-title":"Diabetologia"},{"key":"762_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1084\/jem.189.5.865","volume":"189","author":"M Kerschensteiner","year":"1999","unstructured":"Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189:865\u201370.","journal-title":"J Exp Med"},{"key":"762_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37:1553\u201361.","journal-title":"Neuropharmacology"},{"key":"762_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029405","volume":"6","author":"Y Bejot","year":"2011","unstructured":"Bejot Y, Mossiat C, Giroud M, Prigent-Tessier A, Marie C. Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS One. 2011;6:e29405.","journal-title":"PLoS One"},{"key":"762_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10815-007-9169-y","volume":"24","author":"P Monteleone","year":"2007","unstructured":"Monteleone P, Artini PG, Simi G, Cela V, Casarosa E, Begliuomini S, et al. Brain derived neurotrophic factor circulating levels in patients undergoing IVF. J Assist Reprod Genet. 2007;24:477\u201380.","journal-title":"J Assist Reprod Genet"},{"key":"762_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010099","volume":"5","author":"E Golden","year":"2010","unstructured":"Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore longitudinal study of aging. PLoS One. 2010;5:e10099.","journal-title":"PLoS One"},{"key":"762_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0008-6363(97)00039-4","volume":"34","author":"GY Lip","year":"1997","unstructured":"Lip GY, Blann A. Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255\u201365.","journal-title":"Cardiovasc Res"},{"key":"762_CR32","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.12659\/MSM.890911","volume":"20","author":"J Ding","year":"2014","unstructured":"Ding J, Chen Q, Zhuang X, Feng Z, Xu L, Chen F. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease. Med Sci Monit. 2014;20:2421\u20139.","journal-title":"Med Sci Monit"},{"key":"762_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/14017430600925300","volume":"40","author":"J Ruef","year":"2006","unstructured":"Ruef J, Marz W, Winkelmann BR. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (a subgroup analysis from the Ludwigshafen risk and cardiovascular health study). Scand Cardiovasc J. 2006;40:274\u20139.","journal-title":"Scand Cardiovasc J"},{"key":"762_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1515\/jpem-2012-0159","volume":"25","author":"Q Li","year":"2012","unstructured":"Li Q, Zhang Z, Du R, Hu X, Yan Y, Gao Q, et al. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2012;25:711\u20136.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"762_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1113\/expphysiol.2009.048512","volume":"94","author":"P Rasmussen","year":"2009","unstructured":"Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94:1062\u20139.","journal-title":"Exp Physiol"},{"key":"762_CR36","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/db10-1371","volume":"60","author":"D Navaratna","year":"2011","unstructured":"Navaratna D, Guo SZ, Hayakawa K, Wang X, Gerhardinger C, Lo EH. Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes. 2011;60:1789\u201396.","journal-title":"Diabetes"},{"key":"762_CR37","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","volume":"23","author":"PH Whincup","year":"2002","unstructured":"Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:1764\u201370.","journal-title":"Eur Heart J"},{"key":"762_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1111\/j.1538-7836.2009.03574.x","volume":"7","author":"SG Wannamethee","year":"2009","unstructured":"Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost. 2009;7:1605\u201311.","journal-title":"J Thromb Haemost"},{"key":"762_CR39","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1538-7836.2012.04771.x","volume":"10","author":"JE van Loon","year":"2012","unstructured":"van Loon JE, Kavousi M, Leebeek FW, Felix JF, Hofman A, Witteman JC, et al. Von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population. J Thromb Haemost. 2012;10:1262\u20139.","journal-title":"J Thromb Haemost"},{"key":"762_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055175","volume":"8","author":"P Willeit","year":"2013","unstructured":"Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G, et al. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One. 2013;8:e55175.","journal-title":"PLoS One"},{"key":"762_CR41","doi-asserted-by":"crossref","first-page":"30640","DOI":"10.18632\/oncotarget.5855","volume":"6","author":"H Jiang","year":"2015","unstructured":"Jiang H, Huang S, Li X, Li X, Huang S, Zhang Y, et al. Endothelial tyrosine kinase receptor B prevents VE-cadherin cleavage and protects against atherosclerotic lesion development in ApoE\u2212\/\u2212 mice. Oncotarget. 2015;6:30640\u20139.","journal-title":"Oncotarget"},{"key":"762_CR42","doi-asserted-by":"publisher","first-page":"516783","DOI":"10.1155\/2015\/516783","volume":"2015","author":"N Noren Hooten","year":"2015","unstructured":"Noren Hooten N, Ejiogu N, Zonderman AB, Evans MK. Protective effects of BDNF against C-reactive protein-induced inflammation in women. Mediat Inflamm. 2015;2015:516783.","journal-title":"Mediat Inflamm"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0762-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:49:13Z","timestamp":1660420153000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0762-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0762-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"25 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants gave full written informed consent, and the study was approved by the Committee of Clinical Investigation of Southeast University School of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Application.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}